As a result, PSA is frequently elevated in patients with prostate cancer and has become a classic biomarker for disease diagnosis [430], whereas an AR-mediated transcription program increases cell proliferation [431] and changes central metabolism and biosynthesis [432], leading to disease progression [433]. Here, AR is linked to Familial prostate cancer.